跳至主要内容
临床试验/NCT05974696
NCT05974696招募中不适用

A Research Registry on Aggressive PitNETs

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Characterisation of aggressiveness of pituitary tumours by tanscriptome analysis

研究概览

简要总结

To allow the identification of markers, it is necessary to extend research networks more widely to collect and properly explore aggressive pituitary tumours. The multidisciplinary consultation meeting (RCP), organised by the reference centre for rare diseases of the pituitary gland, dedicated to aggressive pituitary tumours and carcinomas (HYPOcare), which is unique in France and brings together national experts, currently makes it possible to orientate the management of patients with an aggressive pituitary tumour. With more than 80 patient files discussed since its inception, the patient cohort via the HYPOcare RCP is one of the largest both nationally and internationally. At present, this data source is only dedicated to the clinical management of the files without the possibility of carrying out research work

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Characterisation of aggressiveness of pituitary tumours by tanscriptome analysis

时间窗: 3 years

Molecular and transcriptomic signature of aggressiveness of pituitary tumours predictive of prognosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验